Jennifer Shutt covers the nation’s capital as a senior reporter for States Newsroom. Her coverage areas include congressional policy, politics and legal challenges with a focus on health care, unemployment, housing and aid to families.
The timeline for moving the next generation of COVID-19 vaccines to doctors’ offices and pharmacies will be determined by the data and how effective they may be when compared with the current vaccines, said a federal health official.
More than 400 pharmaceutical companies, including Pfizer, wrote an open letter expressing concerns about the precedent that could be set if one U.S. district court judge can overturn the FDA’s scientific and medical judgment in approving pharmaceuticals.
The timeline for moving the next generation of COVID-19 vaccines to doctors’ offices and pharmacies will be determined by the data and how effective they may be when compared with the current vaccines, said a federal health official.
More than 400 pharmaceutical companies, including Pfizer, wrote an open letter expressing concerns about the precedent that could be set if one U.S. district court judge can overturn the FDA’s scientific and medical judgment in approving pharmaceuticals.
